Arrivent BioPharma, Inc. (AVBP)
30.34
+0.60
(+2.02%)
USD |
NASDAQ |
Sep 22, 16:00
30.34
0.00 (0.00%)
After-Hours: 18:30
Arrivent BioPharma Total Assets (Quarterly) : 394.72M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 394.72M |
| March 31, 2026 | 349.30M |
| December 31, 2025 | 333.17M |
| September 30, 2025 | 326.56M |
| June 30, 2025 | 269.51M |
| March 31, 2025 | 215.50M |
| December 31, 2024 | 274.94M |
| September 30, 2024 | 292.71M |
| Date | Value |
|---|---|
| June 30, 2024 | 308.86M |
| March 31, 2024 | 327.84M |
| December 31, 2023 | 163.10M |
| September 30, 2023 | 182.09M |
| June 30, 2023 | 198.84M |
| March 31, 2023 | |
| December 31, 2022 | 182.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cytokinetics, Inc. | 1.925B |
| Gilead Sciences, Inc. | 49.36B |
| Ionis Pharmaceuticals, Inc. | 2.995B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.88M |
| Shareholders Equity (Quarterly) | 366.84M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 14.16 |
| Net Debt Paydown Yield | 0.00% |